These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3622862)

  • 41. Therapeutic strategy of nephrotic syndrome in patients over eighty.
    Noiri E; Okuda T; Takano T; Kurokawa K
    Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):902-6. PubMed ID: 7933665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
    Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
    Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy.
    Suzuki H; Furukawa M; Kumagai M; Takahashi E; Matsuura K; Katori Y; Shimomura A; Kobayashi T
    Acta Otolaryngol; 2003 Jan; 123(1):46-50. PubMed ID: 12625572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
    Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
    J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Usefulness of inhaled steroids in steroid-dependent intractable asthma--equivalent dose of oral steroid to inhaled steroid].
    Takahashi K; Kotoh N; Soda R; Tada S; Tanizaki Y; Kimura I
    Arerugi; 1994 Sep; 43(9):1163-71. PubMed ID: 7802600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Low-dose prednisolone therapy for idiopathic thrombocytopenic purpura].
    Ohmine K; Izumi T; Muroi K; Shimizu R; Imagawa S; Komatsu N; Sasaki R; Hatake K; Miura Y; Ozawa K
    Rinsho Ketsueki; 2000 Jan; 41(1):8-11. PubMed ID: 10695392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy.
    Horita Y; Tadokoro M; Taura K; Ashida R; Hiu M; Taguchi T; Furusu A; Kohno S
    Ren Fail; 2007; 29(4):441-6. PubMed ID: 17497466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacokinetics of prednisone and prednisolone.
    Pickup ME
    Clin Pharmacokinet; 1979; 4(2):111-28. PubMed ID: 378499
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
    Kroschinsky FP; Friedrichsen K; Mueller J; Pursche S; Haenel M; Prondzinsky R; Ehninger G; Schleyer E
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):785-90. PubMed ID: 17579865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome.
    Fujieda M; Ishihara M; Morita T; Hayashi A; Utsunomiya Y; Ohta T; Sakano T; Wakiguchi H
    Clin Nephrol; 2008 Mar; 69(3):179-84. PubMed ID: 18397716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
    Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Sasatomi Y; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
    Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors.
    Gelderblom H; Salazar R; Verweij J; Pentheroudakis G; de Jonge MJ; Devlin M; van Hooije C; Seguy F; Obach R; Pruñonosa J; Principe P; Twelves C
    Clin Cancer Res; 2003 Sep; 9(11):4101-7. PubMed ID: 14519632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of famotidine in infants.
    Wenning LA; Murphy MG; James LP; Blumer JL; Marshall JD; Baier J; Scheimann AO; Panebianco DL; Zhong L; Eisenhandler R; Yeh KC; Kearns GL
    Clin Pharmacokinet; 2005; 44(4):395-406. PubMed ID: 15828852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
    Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral corticosteroid therapy and present disease status in myasthenia gravis.
    Imai T; Suzuki S; Tsuda E; Nagane Y; Murai H; Masuda M; Konno S; Suzuki Y; Nakane S; Fujihara K; Suzuki N; Utsugisawa K
    Muscle Nerve; 2015 May; 51(5):692-6. PubMed ID: 25155615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.
    Cheng H; Leff JA; Amin R; Gertz BJ; De Smet M; Noonan N; Rogers JD; Malbecq W; Meisner D; Somers G
    Pharm Res; 1996 Mar; 13(3):445-8. PubMed ID: 8692739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs.
    Hammami MM; Yusuf A; Shire FS; Hussein R; Al-Swayeh R
    J Negat Results Biomed; 2017 May; 16(1):10. PubMed ID: 28535819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.